Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 14, 2016Diabetes Care

Growth Differentiation Factor 15 as a Novel Biomarker for Metformin

View Full Paper
Ask AI
Bookmark
Share

Authors

Hertzel C. Gerstein
Hertzel C. GersteinMarquette UniversityGPGuillaume ParéGeneral / Preventive / LipidsSHSibylle HessBMW (Germany)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gerstein et al. (2016) studied this question.

synapsesocial.com/papers/69dd4bbf99c691022d99bd53https://doi.org/10.2337/dc16-1682
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia2015 · 70 citations
  2. 210-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes2008 · 7,833 citations
  3. 3Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin2002 · 19,199 citations
  4. 4Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes2013 · 82 citations
  5. 5Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis2011 · 223 citations